Hochschulschrift
Inhibition of Polo-like Kinase 1 by Small Molecules Targeting the Polo-Box Domain
- Alternative title
-
Identifizierung von niedermolekularen Inhibitoren der Polo-Box Domäne von Polo-like Kinase1
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Technische Universität München, Diss., 2008
- Keyword
-
Coenzym
Enzymologie
Cofaktor
Enzym
Biochemische Analyse
Pflanzenphysiologie
Hahnenfußartige
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der TU München
- (when)
-
2008
- Creator
- Contributor
- URN
-
urn:nbn:de:bvb:91-diss-20080505-650458-1-7
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Reindl, Wolfgang
- Kessler, Horst
- Berg, Thorsten
- Küster, Bernhard
- Universitätsbibliothek der TU München
Time of origin
- 2008
Other Objects (12)
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Combinatorial treatment of lung cancer monolayer cells and their spheroids with tyrosine kinase inhibitors and Salinomycin
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Screening for anti-cancer molecules inhibiting polo-like kinase 1
A Systematical Analysis of the Signal Transduction Pathways Induced by the Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
Salivaproteomik – Optimierung, Etablierung und Realisierung von proteomischen Strategien zur Untersuchung von pathologie-assoziierten Proteinsignaturen in humaner Saliva aus populationsbasierten Studien
Chemoproteomic characterization of covalent target engagement in cells
Mass spectrometry based chemical proteomics for drug selectivity profiling
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Combinatorial treatment of lung cancer monolayer cells and their spheroids with tyrosine kinase inhibitors and Salinomycin
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Screening for anti-cancer molecules inhibiting polo-like kinase 1
A Systematical Analysis of the Signal Transduction Pathways Induced by the Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
Salivaproteomik – Optimierung, Etablierung und Realisierung von proteomischen Strategien zur Untersuchung von pathologie-assoziierten Proteinsignaturen in humaner Saliva aus populationsbasierten Studien
Chemoproteomic characterization of covalent target engagement in cells
Mass spectrometry based chemical proteomics for drug selectivity profiling
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Combinatorial treatment of lung cancer monolayer cells and their spheroids with tyrosine kinase inhibitors and Salinomycin
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Screening for anti-cancer molecules inhibiting polo-like kinase 1
A Systematical Analysis of the Signal Transduction Pathways Induced by the Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
Salivaproteomik – Optimierung, Etablierung und Realisierung von proteomischen Strategien zur Untersuchung von pathologie-assoziierten Proteinsignaturen in humaner Saliva aus populationsbasierten Studien
Chemoproteomic characterization of covalent target engagement in cells